Patents/Assignees

Metriopharm AG

2 patents in portfolio

US12616695utility2026
Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the Treatment of Rare Chronic Inflammatory Pulmonary Diseases
0 cites
US12122753utility2024
Method for Solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione
0 cites